Bernard Sagaert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bernard sagaert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bernard Sagaert Today - Breaking & Trending Today

Almirall signs alliance with etherna for new mRNA-based therapies

Almirall has signed multi-target alliance with etherna to develop mRNA-based therapies to address severe skin diseases, including non-melanoma skin cancer. ....

Bernard Sagaert , Karl Ziegelbauer ,

Almirall and etherna partner to develop mRNA-based therapies for severe skin diseases

Almirall and etherna partner to develop mRNA-based therapies for severe skin diseases
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

Karl Ziegelbauer , Bernard Sagaert , Integrated Drug Creation , Nostrum Biodiscovery ,

Almirall, S.A.: Almirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatology

Almirall, S.A.: Almirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatology
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Comunidad Autonoma De Cataluna , United States , Bernard Sagaert , Stefan Klotter , Richard Hayhurst , Karl Ziegelbauer , Omar Ram , Corporate Communications , Spanish Stock Exchange , Chief Scientific Officer , Noble Purpose , Divasson Del Fraile , Lassen Sie ,

Almirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatology

BARCELONA, Spain & NIEL, Belgium, December 12, 2023 Almirall, S.A. (ALM), a global pharmaceutical company focused on medical dermatology, and etherna, an mRNA/LNP technology platform company, announced today a multi-target alliance to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. ....

United States , Comunidad Autonoma De Cataluna , Karl Ziegelbauer , Richard Hayhurst , Bernard Sagaert , Omar Ram , Spanish Stock Exchange , Corporate Communications , Chief Scientific Officer , Noble Purpose , Global Pharmaceutical Company , Skin Diseases , Research And Development , Technology Platform Company ,